Merck Files 10-K/A Amendment for FY 2023

Ticker: MRK · Form: 10-K/A · Filed: 2024-04-11T00:00:00.000Z

Sentiment: neutral

Topics: amendment, annual-report, regulatory-filing

TL;DR

Merck filed an update to its 2023 annual report (10-K/A) on April 11, 2024.

AI Summary

Merck & Co., Inc. filed an amendment (10-K/A) on April 11, 2024, for its fiscal year ending December 31, 2023. This filing provides updated information for the annual report, which is a standard regulatory requirement for publicly traded companies like Merck.

Why It Matters

This amendment ensures Merck's annual financial reporting is accurate and up-to-date, providing investors and regulators with the latest information on the company's performance and disclosures.

Risk Assessment

Risk Level: low — This filing is an amendment to a standard annual report, indicating routine updates rather than significant new risks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 10-K/A filing?

This 10-K/A filing is an amendment to Merck & Co., Inc.'s annual report for the fiscal year ended December 31, 2023.

When was this amendment filed with the SEC?

The amendment was filed with the Securities and Exchange Commission on April 11, 2024.

What is Merck & Co., Inc.'s primary business?

Merck & Co., Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.

Where is Merck & Co., Inc. headquartered?

Merck & Co., Inc.'s business and mailing address is 2000 Galloping Hill Road, Kenilworth, NJ 07033.

What is the SEC file number for Merck & Co., Inc.?

The SEC file number for Merck & Co., Inc. is 001-06571.

From the Filing

0001193125-24-093194.txt : 20240411 0001193125-24-093194.hdr.sgml : 20240411 20240411160538 ACCESSION NUMBER: 0001193125-24-093194 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 24838538 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 10-K/A 1 d807955d10ka.htm 10-K/A 10-K/A true 0000310158 FY 0000310158 2023-01-01 2023-12-31 0000310158 2023-06-30 0000310158 2024-01-31 0000310158 mrk:A2.500NotesDue2034Member 2023-01-01 2023-12-31 0000310158 mrk:A1.375NotesDue2036Member 2023-01-01 2023-12-31 0000310158 mrk:A0.500NotesDue2024Member 2023-01-01 2023-12-31 0000310158 mrk:A1.875NotesDue2026Member 2023-01-01 2023-12-31 iso4217:USD xbrli:shares As filed with the Securities and Exchange Commission on April 11, 2024       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549     FORM 10-K/A (Amendment No. 1)       ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31 , 2023 OR   ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from       to       Commission File No.  1-6571       Merck & Co., Inc.     126 East Lincoln Avenue Rahway New Jersey 07065 ( 908 ) 740-4000   New Jersey   22-1918501 (State or other jurisdiction of incorporation)   (I.R.S. Employer Identification No.) Securities Registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Each Exchange on which Registered Common Stock ($0.50 par value)   MRK   New York Stock Exchange 0.500% Notes due 2024   MRK 24   New York Stock Exchange 1.875% Notes due 2026   MRK/26   New York Stock Exchange 2.500% Notes due 2034   MRK/34   New York Stock Exchange 1.375% Notes due 2036   MRK 36A   New York Stock Exchange     Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes  ☒  No  ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.   Yes  ☐  No   ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   ☒  No  ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes   ☒  No  ☐ Indicate by che

View on Read The Filing